Samsung C&T and Samsung Electronics, major shareholders of Samsung Biologics, will jointly make a two-trillion-won equity investment in the biotech subsidiary.The two companies participated in Samsung Biologics' paid-in capital increase of 3.2 trillion won. Samsung Biologics is increasing its ca
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. In the global market, valuation multiples for the medical device sector are higher than those of the pharmaceutical arena. In the domestic market, however, the situation is opposite. We expect re-rat
KT announced on March 16 that it has signed a strategic business agreement with MenuTalk, a company specializing in an unmanned ordering platform, to promote the use of artificial intelligence (AI)-powered service robots.MenuTalk is a company that develops solutions and IoT software for restaurants.
Chong Kun Dang Bio announced on March 10 that it has recently signed a contract manufacturing organization (CMO) contract with biotech startup EnhancedBio for production of the key material for engineered ionizable lipid nanoparticle (EN-LNP) technology.EN-LNP is a technology for targeted delivery o
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on March 2 that South Korean biotech and pharmaceutical companies exported 32 technologies equivalent to 13.372 trillion won last year. For reference, the latter was 1.48 trillion won, 5.73 trillion won, 8.51 trillion won an
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. In February, the m-m fall in major NYSE bio indices narrowed versus the January figures. We view overweighting within IBB on leading new drug companies such as Amgen and Vertex Pharma as being a sign
The author is an analyst of KB Securities. He can be reached at kimtaehee@kbfg.com. -- Ed. Maintain BUY, lower target price from KRW86,000 to KRW75,000 We lower our TP on Yuhan Corp. (KRW86,000→KRW75,000). We adjust WACC (7.49%→7.76%), risk-free rate (1.02%→1.29%) and market risk premium (7.36%→7.16
Incheon City Mayor Park Nam-chun took office in July 2018. Since then, the city has accelerated its growth as a hub of Korea's future industries. The following is a recent interview with him, whose term is scheduled to end on June 30. – Ed.What would you pick as your best achievements as the may
KT will participate in this year's Mobile World Congress (MWC), which will be held for the first time in three years.KT announced on Feb. 20 that it will run an exhibition hall at MWC 2022, which will run in Barcelona, Spain, from Feb. 28 to March 3 (local time). The KT exhibition hall, formed u
The Korea Basic Science Institute (KBSI) announced on Feb. 17 that it has developed a gargle for early COVID-19 diagnosis in cooperation with Bio3S and Jeonbuk National University Hospital.Angiotensin-converting enzyme 2, where coronavirus bonding can occur, can be found in quantity in the human ora
The author is an analyst of NH Investment & Securities. He can be reached at esshim@nhqv.com. -- Ed. H.PIO specializes in health functional food manufacturing and brand marketing. The firm is expanding the business scope for its premium brand, Denps, including adding vitamin offerings to the product
The author is an analyst of NH Investment & Securities. He can be reached at hwdoh@nhqv.com. -- Ed. According to Sumco, silicon wafers are likely to be scarce through 2026, with the silicon wafer market projected to grow at a 2021~2025F CAGR of 10.2%. Wafer demand is to be impacted by rising process
MedPacto, Inc., a genome-based drug discovery and clinical-stage biotechnology company, announced on Feb. 14 that it has entered into a clinical trial agreement with University Hospitals Cleveland Medical Center in the United States to pursue an investigator-initiated clinical trial in patients with
MedPacto, Inc., a genome-based drug discovery and clinical-stage biotechnology company, announced on Feb. 11 that it has partnered with HITS, an artificial intelligence (AI) drug discovery company, to co-develop new drugs.Under the terms of the agreement, the two companies will practice drug develop
Starting with an artificial intelligence (AI) speaker partnership with Amazon, KT is expanding the scope of cooperation with Amazon. In the process of KT’s transition to a digital platform company (Digico), this partnership is expected to provide a bridgehead for KT to explore overseas markets.KT an
SK Bioscience has started to ship the Novavax COVID-19 vaccine. The company announced on Feb. 9 that it began shipping pre-filled syringes of Nuvaxovid, Korea’s first synthetic antigen COVID-19 vaccine, from L House in Andong, North Gyeongsang Province. The Korean drugmaker is scheduled to ship abou
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. In January, NYSE pharmaceuticals indices tumbled, with both large caps and small caps being weighed upon by adverse macro conditions. However, the coupling between Covid-19 sentiment and biotech appe
Chong Kun Dang's R&D spending reached 112.6 billion won in 2021, up 19.2 percent from 94.5 billion won a year earlier, according to the company's recently released quarterly report. The company's R&D investment crossed 100 billion won in the first three quarters of 2021.The ratio of R&D
Hankook & Company Co., the holding company of Hankook Tire & Technology Co., has appointed Kim Seong-jin as chief digital officer (CDO) to accelerate the group's digital transformation. As head of the Digital Strategy Department, Kim will establish an innovation model based on advanced digital t
The Electronics and Telecommunications Research Institute (ETRI) announced on Jan. 26 that it has developed Deep Learning Compiler Nest (NEST-C), AI system software that can solve compatibility and scalability problems between hardware and software.A compiler refers to a program that converts progra